2022³â °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Á¤½Å°Ç°ÀÇÇб³½Ç ¿¬¼ö±³À° : 2022-08-27±³À°ÀÏÀÚ : 2022-08-27
±³À°Àå¼Ò : °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ º»°ü 3Ãþ ÃÖ´ö°æ °ÀǽÇ(320È£)
±³À°ÁÖÁ¦ :
2022³â °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Á¤½Å°Ç°ÀÇÇб³½Ç ¿¬¼ö±³À°ÁÖÃÖ±â°ü : °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ
´ã´çÀÚ : °í¹Î¼ö
¿¬¶ôó : 02-920-5815
À̸ÞÀÏ :
ms1505@hanmail.net ±³À°Á¾·ù : Á¤½Å°Ç°ÀÇÇаú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 40,000¿ø
ºñ°í Àü¹®ÀÇ ¹× °ü·ÃÀü¹®°¡: »çÀüµî·Ï-3¸¸¿ø/ÇöÀåµî·Ï-4¸¸¿ø, Àü°øÀÇ,±ºÀÇ°ü,°øº¸ÀÇ: »çÀüµî·Ï 2¸¸¿ø/ÇöÀåµî·Ï 3¸¸¿ø, Çлý/µ¿¹®: ¸éÁ¦
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-27 ÃÖ´ö°æ°ÀÇ½Ç 14:40~15:05 Neuroimaging biomarkers in adolescent mood disorders ÀÌÁ¾ÇÏ(°í·Á´ëÇб³ ¾È»êº´¿ø)
±³À°½Ã°£ 08-27 ÃÖ´ö°æ°ÀÇ½Ç 15:05~15:30 Digital phenotypes in anxiety disorders Á¶Ã¶Çö(¼¼Á¾Ãæ³²´ëÇб³ º´¿ø)
±³À°½Ã°£ 08-27 ÃÖ´ö°æ°ÀÇ½Ç 15:30~15:55 Amyloidopathy in Alzheimer¡¯s disease: neuropathology, diagnostic maker and therapeutic target Á¤Çö°(°í·Á´ëÇб³ ±¸·Îº´¿ø)
Åä·Ð 08-27 ÃÖ´ö°æ°ÀÇ½Ç 15:55~16:05 Åä·Ð ()
±³À°½Ã°£ 08-27 ÃÖ´ö°æ°ÀÇ½Ç 16:15~16:55 Do we need a new paradigm for mental illness? ±è¿ë±¸(°í·Á´ëÇб³ ¾È»êº´¿ø)
Åä·Ð 08-27 ÃÖ´ö°æ°ÀÇ½Ç 16:55~17:05 Åä·Ð ()
±³À°½Ã°£ 08-27 ÃÖ´ö°æ°ÀÇ½Ç 17:15~17:40 Ä¡·á ÀúÇ×¼º ¿ì¿ïÁõ ȯÀÚ¸¦ À§ÇÑ Nasal esketamine spray ½Åö¹Î(°í·Á´ëÇб³ ¾È»êº´¿ø)
±³À°½Ã°£ 08-27 ÃÖ´ö°æ°ÀÇ½Ç 17:40~18:05 ¶Ç ÇϳªÀÇ Ä¡·á µµ±¸, Neuromodulation treatment ±èÁØÇü(°í·Á´ëÇб³ ±¸·Îº´¿ø)
±³À°½Ã°£ 08-27 ÃÖ´ö°æ°ÀÇ½Ç 18:05~18:30 ¿Ü·¡ ±â¹Ý Á¤½ÅÄ¡·á: From CBT to digital therapeutics ÇѱԸ¸(°í·Á´ëÇб³ ¾È¾Ïº´¿ø)